05.06.2024 15:06:09 - dpa-AFX: *AMGEN'S UPLIZNA SHOWS PROMISE IN PHASE 3 TRIAL FOR IMMUNOGLOBULIN G4-RELATED DISEASE

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
AMGEN INC. DL-,0001 867900 Xetra 289,900 21.06.24 17:35:31 +3,700 +1,29% 0,000 0,000 289,450 289,900

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH